Skip to main content

Biotin

ADVERTISEMENT
Identification
Molecular formula
C10H16N2O3S
CAS number
58-85-5
IUPAC name
5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoic acid
State
State

Biotin is typically solid at room temperature, existing as a stable crystalline powder.

Melting point (Celsius)
232.00
Melting point (Kelvin)
505.15
Boiling point (Celsius)
0.00
Boiling point (Kelvin)
0.00
General information
Molecular weight
244.31g/mol
Molar mass
244.3100g/mol
Density
1.4080g/cm3
Appearence

Biotin appears as a white, crystalline powder. It is water-soluble and stable when exposed to air and heat, although it may degrade upon exposure to strong acids or bases.

Comment on solubility

Solubility of 5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoic acid

The solubility of the compound with the formula C10H16N2O3S can be influenced by various factors. This specific compound is characterized by a complex structure that includes both hydrophilic and hydrophobic components, which can play a significant role in its solubility profile.

  • Hydrophilicity: The presence of functional groups such as carbonyl (C=O) and carboxylic acid (-COOH) enhances its ability to interact with water, suggesting that its solubility in aqueous solutions may be relatively favorable.
  • Hydrophobicity: However, the thieno[3,4-d]imidazole moiety introduces some hydrophobic characteristics, which could impede solubility under certain conditions.
  • pH Dependence: The solubility may also vary with pH, as the carboxylic acid can ionize in basic environments, increasing the compound's solubility in alkaline solutions.

Therefore, it can be said that the compound is expected to exhibit moderate solubility in water, with the potential for higher solubility in alkaline conditions. Understanding the balance between the hydrophilic and hydrophobic elements is essential for predicting its behavior in different solvents.

Interesting facts

Exploring 5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoic acid

5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoic acid is a fascinating compound with unique structural characteristics and significant potential in various fields of research. Here are some intriguing facts that highlight its importance:

  • Pharmaceutical Potential: This compound is notable for its potential application in drug design. Its intricate structure may serve as a lead for synthesizing novel medicinal compounds.
  • Bioactivity: Many compounds with similar structural motifs exhibit interesting bioactivity, including anti-inflammatory and anti-cancer properties. Ongoing studies may uncover similar characteristics in this compound.
  • Structural Complexity: The compound features a thieno[3,4-d]imidazole ring system, showcasing a confluence of sulfur and nitrogen in its heterocyclic structure. This complexity often correlates with enhanced biological activity.
  • Research Interest: This compound's unique features have drawn scientists' attention, making it a subject of research in synthetic organic chemistry and pharmacology. The quest for understanding its interactions within biological systems continues.

As a chemistry student, one might find it intriguing to explore the synthetic pathways leading to compounds like this. The exploration of the compound's potential applications in various therapeutic areas could also be a rewarding intellectual pursuit. Scientists often say, "Chemistry is the art of creating new materials to improve the quality of life." This statement resonates particularly well when considering the implications of such complex compounds.

By delving into the structure and possible applications of 5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoic acid, we can appreciate the depth and breadth of chemical research and its impact on real-world challenges.

Synonyms
57378-70-8
5-(2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid
5-(2-Oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-pentanoic acid
MLS000736711
dl-Biotin
22879-79-4
5-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazolidin-4-yl}pentanoic acid
22377-59-9
1H-Thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-, [3as-(3a.alpha.,4.beta.,6a.alpha.)]-
SMR000135188
SR-01000665783
NSC63865
5-(2-oxo-hexahydro-1H-thieno(3,4-d)imidazolidin-4-yl)pentanoic acid
NCGC00094984-04
1217850-77-5
Spectrum_000225
Spectrum2_001510
Spectrum3_000665
Spectrum4_001061
Spectrum5_001139
component of Deca-Vi-Sol
SCHEMBL59420
BSPBio_002329
KBioGR_001382
KBioSS_000705
MLS000530211
DivK1c_000311
SPECTRUM1503009
SPBio_001559
(3aR,4S,6aS)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanoic acid
CHEMBL1527083
CHEBI:95156
HMS500P13
KBio1_000311
KBio2_000705
KBio2_003273
KBio2_005841
KBio3_001549
DTXSID00859030
NINDS_000311
HMS1921P22
HMS2092H08
Pharmakon1600-01503009
ALBB-025845
CCG-38885
NSC758208
AKOS000121079
AKOS016344011
component of Deca-Vi-Sol (Salt/Mix)
NSC-758208
SB67329
SDCCGMLS-0066741.P001
IDI1_000311
NCGC00094984-01
NCGC00094984-02
NCGC00094984-03
DS-14362
SY010836
SBI-0051929.P002
DB-113456
NS00005403
EN300-23975
AB00052453_12
SR-01000665783-3
SR-01000665783-4
BRD-A36603537-001-07-3
BRD-A36603537-001-12-3
BRD-A36603537-001-13-1
Q27166951
5-(2-Oxo-hexahydro-thieno[3,4-d]imidazol-4-yl)-pentanoic acid
5-(2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoicacid
1H-Thieno[3, hexahydro-2-oxo-, [3aS-(3a.alpha.,4.beta.,6a.alpha.)]-
1H-Thieno[3,4-d]imidazole-4-pentanoicacid, hexahydro-2-oxo-, (3aR,4R,6aS)-rel-
5-(2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid, cis-(+)- #
840-986-7